Feb. 9, 2022—Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.
Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track
May. 27, 2021—A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.
Apr. 29, 2021—Bradley Malin, PhD, professor of Biomedical Informatics, Biostatistics and Computer Science, has been appointed to the Board of Scientific Counselors (BSC) of the National Center for Health Statistics (NCHS) of the U.S. Centers for Disease Control and Prevention (CDC) through 2024.
Sep. 11, 2020—Eating at dine-in restaurants appears to increase the risk of becoming sick with COVID-19, according to a recent study by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University Medical Center.
Mar. 26, 2020—The prevalence of autism spectrum disorder among U.S. 8-year-olds rose 10% between 2014 and 2016, new data published today by the Centers for Disease Control and Prevention (CDC) indicate.
Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
Aug. 19, 2019—Effective Dec. 2, 2019, all employees previously grandfathered into measles compliance with a record of only one MMR vaccine will need to have a second vaccine to be considered up to date.
Mar. 25, 2019—Researchers at Vanderbilt University Medical Center are participating in a national effort to develop vaccines and other treatments as countermeasures to prevent the spread of two emerging and deadly viruses — Nipah and Hendra.